First Time Loading...

Addex Therapeutics Ltd
SIX:ADXN

Watchlist Manager
Addex Therapeutics Ltd Logo
Addex Therapeutics Ltd
SIX:ADXN
Watchlist
Price: 0.062 CHF -6.63% Market Closed
Updated: Jun 9, 2024

Addex Therapeutics Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Addex Therapeutics Ltd
Net Income Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Addex Therapeutics Ltd
SIX:ADXN
Net Income
-CHf10.6m
CAGR 3-Years
6%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Net Income
-CHf54.6m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Net Income
-$217.1m
CAGR 3-Years
18%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Net Income
CHf10.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Net Income
-CHf297.9m
CAGR 3-Years
13%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Net Income
-CHf13.3m
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
N/A

See Also

What is Addex Therapeutics Ltd's Net Income?
Net Income
-10.6m CHF

Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Net Income amounts to -10.6m CHF.

What is Addex Therapeutics Ltd's Net Income growth rate?
Net Income CAGR 5Y
-45%

Over the last year, the Net Income growth was 49%. The average annual Net Income growth rates for Addex Therapeutics Ltd have been 6% over the past three years , -45% over the past five years .